Akashi Therapeutics, Inc.

Sarepta Therapeutics Inc. has licensed rights to two gene therapy research programs underway at the Nationwide Children’s Hospital, Columbus, Ohio, adding new projects to its growing Duchenne muscul

Sarepta Therapeutics Inc. ’s recent first-ever US FDA approval for a drug to treat Duchenne muscular dystrophy (DMD) is lending confidence for a wave of potential therapies and combination regimens t

IN VITRO DIAGNOSTICS Mergers & Acquisitions Laboratory Corp. of America Holdings LipoScience Inc. Laboratory Corp. of America Holdings acquired publicly traded LipoScience Inc. (diagnostics fo

A team of executives from a small biotech company recently walked into the offices of the venture capital firm BVF Partners with an investment idea. The company was looking for funding for an investig